Related Experiment Video
Updated: Aug 7, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Recent developments in the classification, evaluation, and treatment of insomnia
Michael O Summers1, Maria I Crisostomo, Edward J Stepanski
1Department of Medicine, Rush University Medical Center, Sleep Disorders Center-JRB-6S, 710 S Pauline St, Chicago, IL 60612, USA. michael_summers@rush.edu
Insomnia is a common sleep disorder impacting public health and costing billions annually. Advances in classification and treatment, including cognitive behavioral and pharmacologic therapies, are improving understanding and management.
Area of Science:
- Sleep Medicine
- Clinical Psychology
- Public Health
Background:
- Insomnia is a prevalent outpatient complaint, yet expertise in its diagnosis and treatment remains limited among clinicians.
- The diagnosis and management of insomnia are time-intensive, contributing to challenges in widespread effective care.
- Insomnia carries substantial economic burdens, estimated between $92.5 and $107.5 billion annually, highlighting its significant medical and public health implications.
Purpose of the Study:
- To review recent advances in the classification, evaluation, and treatment of insomnia.
- To highlight the need for standardized definitions and assessment guidelines in insomnia research.
- To underscore the importance of developing consensus for improved data interpretation and clinical practice.
Main Methods:
- Review of recent literature on insomnia classification and evaluation.
- Analysis of established and emerging treatment modalities for insomnia.
- Discussion of the multifactorial etiology of insomnia and its clinical implications.
Main Results:
- Significant progress has been made in defining and measuring insomnia, fostering greater consensus.
- Cognitive behavioral therapies (CBT) and pharmacologic therapies are recognized as effective treatment approaches.
- The multifactorial nature of insomnia necessitates a comprehensive understanding for effective management.
Conclusions:
- Continued research and validation of clinical guidelines are expected to enhance the understanding of insomnia.
- Establishing standardized definitions and assessment tools is crucial for advancing insomnia research and clinical practice.
- Multifaceted approaches combining behavioral and pharmacological interventions are key to managing this complex sleep disorder.
Related Concept Videos
Management of Insomnia
Insomnia
Multiple factors contribute...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Blind Procedures
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...